Total 2 articles
Novo Nordisk sues Hims & Hers over knockoff weight-loss drugs. A David vs Goliath battle over patient access versus Big Pharma patents unfolds.
The US FDA has approved the first-ever pill form of Novo Nordisk's blockbuster weight-loss drug, Wegovy. Showing comparable results to the injection in trials, the daily pill is set to launch in January 2026.
Advertise with Us